Insulet Corp. (PODD) Stock Score, Valuation & Financial Research
Insulet Corp. is in the Healthcare sector and Medical - Devices industry. It is reviewed using Wall Street Score's company-strength, valuation, growth and financial-health framework. The current Wall Street Score is 43/100.
Quick answer for PODD
Insulet Corp. currently has a Wall Street Score of 43/100. The stored market price is $137.8. Its financial score is 29/100. Its valuation score is 10/100. These figures are a research snapshot, not a buy or sell recommendation.
What Insulet Corp. does
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform products comprising Omnipod 5 automated insulin delivery system, which includes a proprietary AID algorithm embedded in the pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless Bluetooth communication; Omnipod DASH insulin management system that features a Bluetooth enabled pod that is controlled by a smartphone-like personal diabetes manager with a color touch screen user interface; and the Omnipod Insulin Management System. It also provides pods for Amgen for use in the Neulasta Onpro kit, which is a delivery system to help reduce the risk of infection after intense chemotherapy. The company sells its products to end-users through the
PODD financial snapshot
- Wall Street Score:
- 43/100
- Current price:
- $137.8
- Market capitalization:
- $9.54B
- Revenue:
- $2.90B
- Net income:
- $302.8M
- Free cash flow:
- $377.7M
- Cash:
- $480.4M
- Total debt:
- $948.1M
- EPS:
- 3.51
- P/E ratio:
- 39.3x
- Financial score:
- 29/100
- Valuation score:
- 10/100
- Revenue score:
- 37/100
What stands out
- Reported year-over-year revenue growth is +0.1%.
- Free cash flow is $377.7M, showing positive cash generation.
- The balance sheet shows $480.4M of cash versus $948.1M of total debt, so leverage deserves attention.
What the numbers mean
Its current valuation score is 10/100, which Wall Street Score classifies as weak within the model's valuation framework.
The financial score is 29/100. This is a starting point for reviewing liquidity, leverage and cash-flow strength rather than a stand-alone recommendation.
A strong company and an attractive stock price are not always the same thing. Revenue, earnings, free cash flow, debt, management quality, competitive advantage and valuation should be considered together. Wall Street Score organizes these inputs into a consistent research framework so investors can identify what deserves deeper review.
Data freshness: Financial data last refreshed 2026-07-24.
How to research PODD
Start by understanding how the company makes money. Then compare revenue and earnings trends, cash generation, debt, liquidity and valuation. Review the company's latest filings and earnings reports before acting on any score or model estimate.
Learn how to analyze a stock · Read the Wall Street Score methodology · Browse other stocks
Data may change as company filings and market prices update. Educational research only; not a buy or sell recommendation.